• Latest Posts

RNAi Therapy is Back: Sanofi is firmly on board to treat Hemophilia

CRISPR meets RNAi: a whole new Targeted Therapy

Genfit’s Non-Invasive Diagnostic could unlock the NASH Market

ADVERTISEMENT